Georg Van Husen MD

Georg van Husen is the Co-Founder and Chief Executive Officer at tenac.io GmbH, Berlin, Germany. He is a former senior health care executive with global responsibility for 6bn EUR business in cardio-metabolic diseases – having changed diabetes treatment with Jardiance and introduced the first reversible oral anticoagulant.